Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms
- PMID: 8402626
Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms
Abstract
The expression of platelet-derived growth factor (PDGF), PDGF-alpha receptor (PDGFR alpha) and PDGF-beta receptor (PDGFR beta) was studied in normal ovaries and ovarian neoplasms by immunohistochemical analysis. PDGF was detected in tumor cells in 33 of 45 malignant tumor samples but in none of 20 benign tumors (P < 0.001) or 11 normal ovaries (P < 0.001). In borderline tumors, 4 of 7 tissues stained positive in tumor cells. PDGFR alpha was detected in tumor cells in 16 of 45 malignant tumors, while no epithelial staining was found in 16 benign tumors (P = 0.002) or in 10 normal ovaries (P = 0.023). In 1 of 7 borderline neoplasms, tumor cells expressed PDGFR alpha. Neither normal epithelium nor tumor cells stained positive with antibodies against PDGFR beta. Patients with ovarian cancer and PDGFR alpha-positive tumor cells demonstrated an overall shorter survival compared to those who had negatively stained tumors (P < 0.005). A similar correlation was found in patients having stage III ovarian cancer (P < 0.01), which further supports an independent role for PDGFR alpha as a prognostic factor. Thus, the concomitant expression of PDGF and PDGFR alpha in tumor cells is related to progression of malignant ovarian tumors, indicating a functional role of PDGF via autocrine growth stimulation.
Similar articles
-
Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.Cancer Res. 1995 Jun 15;55(12):2703-8. Cancer Res. 1995. PMID: 7780988
-
The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.Gynecol Oncol. 1998 Oct;71(1):29-37. doi: 10.1006/gyno.1998.5121. Gynecol Oncol. 1998. PMID: 9784315
-
Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.Hum Pathol. 2005 Mar;36(3):242-9. doi: 10.1016/j.humpath.2004.11.009. Hum Pathol. 2005. PMID: 15791568
-
PDGF receptors in tumor biology: prognostic and predictive potential.Future Oncol. 2014;10(9):1695-708. doi: 10.2217/fon.14.83. Future Oncol. 2014. PMID: 25145436 Review.
-
Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.Tumour Biol. 2016 Aug;37(8):10053-66. doi: 10.1007/s13277-016-5069-z. Epub 2016 May 19. Tumour Biol. 2016. PMID: 27193823 Review.
Cited by
-
Expression of FK506 binding protein 65 (FKBP65) is decreased in epithelial ovarian cancer cells compared to benign tumor cells and to ovarian epithelium.Tumour Biol. 2011 Aug;32(4):671-6. doi: 10.1007/s13277-011-0167-4. Epub 2011 Mar 12. Tumour Biol. 2011. PMID: 21399973
-
Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene.Br J Cancer. 1995 Jul;72(1):35-40. doi: 10.1038/bjc.1995.273. Br J Cancer. 1995. PMID: 7599064 Free PMC article.
-
Olaratumab: A New Strategy in the Treatment of Advanced Soft-Tissue Sarcoma.J Adv Pract Oncol. 2018 Mar;9(2):235-240. Epub 2018 Mar 1. J Adv Pract Oncol. 2018. PMID: 30588358 Free PMC article. Review.
-
KIT promotes tumor stroma formation and counteracts tumor-suppressive TGFβ signaling in colorectal cancer.Cell Death Dis. 2022 Jul 16;13(7):617. doi: 10.1038/s41419-022-05078-z. Cell Death Dis. 2022. PMID: 35842424 Free PMC article.
-
Targeted therapies in epithelial ovarian cancer: Molecular mechanisms of action.World J Biol Chem. 2010 Jul 26;1(7):209-20. doi: 10.4331/wjbc.v1.i7.209. World J Biol Chem. 2010. PMID: 21537476 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous